Dr. Michael Fry, MD

NPI: 1407943194
Total Payments
$1,647
2024 Payments
$687.84
Companies
26
Transactions
87
Medicare Patients
2,607
Medicare Billing
$432,681

Payment Breakdown by Category

Food & Beverage$1,647 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,647 87 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $320.32 16 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $202.41 10 $0 (2024)
PFIZER INC. $141.95 8 $0 (2024)
Janssen Biotech, Inc. $127.87 8 $0 (2023)
Regeneron Healthcare Solutions, Inc. $102.72 4 $0 (2024)
GENZYME CORPORATION $101.94 4 $0 (2024)
Celgene Corporation $95.99 6 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $62.92 4 $0 (2024)
Ipsen Biopharmaceuticals, Inc $60.17 3 $0 (2024)
Merck Sharp & Dohme LLC $54.72 4 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $687.84 34 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($141.30)
2023 $373.84 21 Janssen Biotech, Inc. ($62.80)
2022 $228.54 12 ABBVIE INC. ($89.51)
2021 $124.29 7 AbbVie Inc. ($56.15)
2020 $107.72 6 AbbVie Inc. ($64.26)
2019 $124.46 7 AbbVie, Inc. ($58.12)

All Payment Transactions

87 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/18/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $23.52 General
Category: INFLAMMATION AND IMMUNOLOGY
12/12/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $23.15 General
Category: VIROLOGY
12/11/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $28.12 General
Category: THERAPY FOR CSID
12/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.43 General
Category: Gastroenterology
11/18/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $20.23 General
Category: Rare Disease
11/13/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $28.06 General
Category: Immunology
10/29/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $16.11 General
Category: Gastroenterology
10/01/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.91 General
Category: Gastroenterology
09/30/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $22.29 General
Category: GASTROENTEROLOGY
09/23/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $18.28 General
Category: INFLAMMATION;PAIN
07/29/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $28.62 General
Category: INFLAMMATION AND IMMUNOLOGY
07/25/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.74 General
Category: Neuroscience
07/15/2024 Boston Scientific Corporation WATCHMAN FLX (Device) Food and Beverage In-kind items and services $19.57 General
Category: WATCHMAN FLX_IC
06/26/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.80 General
Category: Gastroenterology
06/13/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $15.84 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
06/06/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $28.88 General
Category: INFLAMMATION AND IMMUNOLOGY
05/17/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $19.39 General
Category: Immunology
05/15/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $22.79 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
05/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.36 General
Category: Gastroenterology
05/08/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $23.32 General
Category: Immunology
05/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.15 General
Category: Neuroscience
04/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $21.98 General
Category: Gastroenterology
04/15/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Food and Beverage In-kind items and services $14.98 General
Category: Gastroenterology
04/10/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.18 General
Category: Neuroscience
03/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.71 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 543 601 $333,287 $54,758
2022 15 536 572 $319,725 $55,294
2021 19 754 3,091 $635,504 $156,395
2020 23 774 3,102 $592,395 $166,234
Total Patients
2,607
Total Services
7,366
Medicare Billing
$432,681
Procedure Codes
72

All Medicare Procedures & Services

72 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 79 80 $75,440 $15,576 20.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 132 187 $51,612 $11,376 22.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 80 80 $48,000 $4,577 9.5%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 22 22 $16,434 $3,683 22.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 27 27 $21,411 $3,069 14.3%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 23 24 $37,344 $2,405 6.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 36 36 $12,204 $2,396 19.6%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 19 19 $14,193 $2,364 16.7%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 12 12 $8,964 $2,084 23.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 13 13 $6,591 $1,550 23.5%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 32 32 $7,072 $1,485 21.0%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 20 20 $8,160 $1,386 17.0%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 12 12 $16,908 $1,213 7.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 24 25 $4,250 $802.87 18.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 12 12 $4,704 $792.27 16.8%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 95 95 $89,585 $18,261 20.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 109 137 $37,812 $8,042 21.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 30 30 $22,410 $5,211 23.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 77 77 $46,200 $4,666 10.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 27 28 $20,916 $3,674 17.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 28 28 $22,204 $2,180 9.8%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 12 12 $8,964 $2,121 23.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $9,633 $2,028 21.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 35 35 $11,865 $1,663 14.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 11 11 $6,468 $1,662 25.7%

About Dr. Michael Fry, MD

Dr. Michael Fry, MD is a Gastroenterology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407943194.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fry, MD has received a total of $1,647 in payments from pharmaceutical and medical device companies, with $687.84 received in 2024. These payments were reported across 87 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,647).

As a Medicare-enrolled provider, Fry has provided services to 2,607 Medicare beneficiaries, totaling 7,366 services with total Medicare billing of $432,681. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Gainesville, GA
  • Active Since 10/06/2006
  • Last Updated 04/15/2019
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1407943194

Products in Payments

  • DUPIXENT (Biological) $204.66
  • XIFAXAN (Drug) $164.32
  • HUMIRA (Biological) $157.09
  • STELARA (Biological) $127.87
  • ZEPOSIA (Drug) $95.99
  • XELJANZ (Drug) $92.87
  • DIFICID (Drug) $54.72
  • ENTYVIO (Biological) $50.13
  • Bylvay (Drug) $39.94
  • Qsymia (Drug) $39.50
  • Humira (Biological) $39.28
  • TRULANCE (Drug) $38.09
  • INJECTAFER (Drug) $37.60
  • SKYRIZI (Biological) $32.91
  • INFLECTRA (Biological) $30.80
  • SUCRAID (Drug) $28.12
  • Mulpleta (Drug) $25.86
  • MAVYRET (Drug) $23.15
  • ZENPEP (Drug) $22.79
  • IBSRELA (Drug) $22.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Gainesville